Vascudyne, Inc. announced today the successful first-in-human use of its TRUE™ Vascular Graft in end-stage renal disease patients requiring hemodialysis access. The first clinical procedures were ...
April 23, 2009 — Five of 10 autologous tissue-engineered vascular grafts, implanted as arteriovenous shunts for hemodialysis access in patients with end-stage renal disease, continued to function ...
DETROIT (WWJ) --A team of physicians at DMC Harper University Hospital announced yesterday that it has successfully treated several patients with a new high-tech "vascular graft" that significantly ...
Establishing and maintaining adequate vascular access is essential to providing an appropriate dialysis dose in patients with end-stage renal disease. Complications related to vascular access have a ...
Dallas, TX - Commenting on a study using endothelial progenitor (EP) cells to create an endothelial lining for artificial arteriovenous grafts [ 1], an editorialist suggests that hemodialysis vascular ...
New York, July 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vascular Access Devices for Hemodialysis (Nephrology and Urology Devices) - Global Market Analysis and ...
Hemodialysis vascular access dysfunction, which causes considerable morbidity, often results from venous stenosis followed by thrombosis in polytetrafluoroethylene (PTFE) grafts. Vascular ...
Patients with Medicare, Medicaid more likely to use arteriovenous fistula, graft by fourth dialysis month. (HealthDay News) — Patients with Medicare or Medicaid are more likely than uninsured patients ...
Aditlys (http://www.aditlys.com/) is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) has received CE Mark for the GORE® Hybrid Vascular Graft. The graft is designed to expand treatment options for optimal outflow by ...
DUBLIN--(BUSINESS WIRE)--The "Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), By ...
Vascudyne, Inc. announced today the successful first-in-human use of its TRUE™ Vascular Graft in end-stage renal disease patients requiring hemodialysis access. The first clinical procedures were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback